HEALTHCARE PRODUCTS

At Synkorp Labs Limited, R&D is a major strength. Synkorp has a team of experienced scientists specializing in Formulation Development, Analytical development and Conducting Stability Studies.

Our dedicated research team is committed to developing a range of formulation and products as per customer specifications and for positively impacting health and well-being.

Our premier R&D infrastructure is located at our manufacturing facility.

KEY RESEARCH & DEVELOPMENT AREAS

Our research effort drives our vision of becoming a respected, profitable and integrated global pharmaceuticals company. A focused effort in defined areas and a lasting interest in new technology are the key features of our efforts.

Our R&D centre is active across almost all facets of the business, which includes:

• Developing generic products and pharmaceutical formulations.
• Identifying niche areas (such as Cardiovascular diseases, Diabetes, and Neuroscience), for product development.
• Post Patent filing for regulated and emerging markets.

OUR STRENGTHS

Our research effort drives our vision of becoming a respected, profitable and integrated global pharmaceuticals company. A focused effort in defined areas and a lasting interest in new technology are the key features of our efforts.

Our R&D centre is active across almost all facets of the business, which includes:

• A full-fledged R&D Centre equipped with the most modern research infrastructure.
• A team of distinguished scientists who can leverage their skills to develop products as per emerging business opportunities.
• An ability to formulate and market drugs in the shortest possible lead time.
• Discover & development of solid, liquid, External & parenteral dosage forms.
• Clarify the factors affecting the clinical development outcomes.
• reformulate existing molecules to enhance their therapeutic application.
• Early and late stage development to complete towards the approval.
• Build efficient R&D to produce innovative products and keep more products in the pipeline. Pharmaceutical R&D management needs a new model of innovation management for enabling innovation and efficiency.